Antigen delivery platforms
US11639370B2 · kind B2 · utility
0Cited by
55References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 28, 2021 |
| Grant date | May 2, 2023 |
| Priority date | — |
| Expiry date | Jun 28, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2840/203
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to platforms for delivery of herpes virus proteins to cells, particularly proteins that form complexes in vivo. In some embodiments these proteins and the complexes they form elicit potent neutralizing antibodies. Thus, presentation of herpes virus proteins using such platforms permits the generation of broad and potent immune responses useful for vaccine development.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.